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O2 tension in driving wound contraction. 
A crucial contribution of this work is 
the demonstration that under hypoxic 
conditions compromised myofibroblast 
contraction is preceded by α-smooth 
muscle actin disassembly from stress 
fibers. Consistent with previous reports 
that the effects of changing O2 tension 
on fibroblast differentiation are revers-
ible (Roy et al., 2003a), Modarressi et 
al. demonstrate that the negative effects 
of hypoxia on fibroblast differentiation 
may be corrected by restoring normox-
ia. Interestingly, Modarressi et al. (2010) 
identify a facilitatory effect of mechani-
cal stimulation in driving fibroblast 
differentiation; this effect was most pro-
nounced under conditions of high oxy-
genation. This observation is relevant to 
negative pressure wound therapy, which 
involves mechanical stimulation and 
during which improved tissue oxygen-
ation is followed by improved wound 
closure (Vikatmaa et al., 2008).
The wound literature is often con-
fusing in terms of the net impact of 
hypoxia on wound closure (Sen, 2009). 
The abundance of literature (primarily 
related to tumor biology) demonstrating 
that hypoxia is a cue for angiogenesis 
has led many to erroneously conclude 
that hypoxia may be helpful for cutane-
ous wound healing. However, from a 
clinical standpoint we know that this is 
unlikely, because ischemic wounds are 
clearly hypoxic, yet refractory to clo-
sure. Acutely, hypoxia may help gener-
ate growth and repair factors necessary 
to lay the foundation for wound closure. 
However, unless there is sufficient oxy-
gen (Sen, 2009), a good foundation for 
healing will not lead to closure. HIF-
dependent hypoxia-inducible microRNA 
miR210 impairs wound epithelialization, 
a key aspect of overall wound closure 
(Biswas et al., 2010). Therefore, although 
stabilization of HIF may elicit angiogenic 
responses, the ultimate effect is to oppose 
wound closure by stalling wound re-epi-
thelialization. The work by Modarressi et 
al. (2010) represents an important con-
tribution to the field of wound healing, 
in which compelling evidence supports 
tissue hypoxia’s conflict with wound clo-
sure. We are reminded that correction 
of wound tissue hypoxia is critical for 
wound tissue to respond to other thera-
peutic interventions.
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Lucky number Seven:  
Rnase 7 Can Prevent Staphylococcus 
aureus Skin Colonization
John S. Cho1, Caiyun Xuan1 and Lloyd S. Miller1
Staphylococcus aureus colonization is a major risk factor for infection. In this 
issue, Simanski et al. demonstrate that the antimicrobial peptide Rnase 7 is 
essential for preventing S. aureus colonization in human skin. These findings 
suggest that therapeutic interventions aimed at targeting Rnase 7 production in 
the skin may be a novel strategy to protect against S. aureus infections.
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antimicrobial peptides and  
skin host defense
Human skin presents both a physical 
and an immunological barrier against 
invading microbial pathogens. In 
addition to contributing to the physical 
barrier, the stratum corneum contains 
antimicrobial peptides that act as a 
first line of defense against pathogenic 
microbial colonization and infection 
by pathogens such as bacteria, fungi, 
and viruses (Lai and Gallo, 2009). 
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Whereas certain antimicrobial peptides 
are present in normal skin, others are 
induced upon exposure to pathogens 
or in response to skin wounding (Miller 
et al., 2005; Sorensen et al., 2006).
The importance of antimicrobial 
peptides in preventing skin infections is 
highlighted in a study by Gallo and col-
leagues demonstrating that mice lack-
ing expression of CRAMP, the mouse 
ortholog of human cathelicidin, are 
highly susceptible to cutaneous infec-
tion by Group A Streptococcus (Nizet 
et al., 2001). Further evidence comes 
from a study by Gläser et al., which 
showed that the antimicrobial peptide 
psoriasin (S100A7) is essential for con-
trolling Escherichia coli colonization on 
skin (Gläser et al., 2005). Gläser et al. 
found that inhibition of psoriasin on the 
surface of healthy human skin promoted 
the persistence of E. coli, indicating that 
psoriasin acts as a primary bactericidal 
factor against E. coli colonization. Thus, 
the production of specific antimicrobial 
peptides on the surface of the skin is 
essential to prevent pathogenic colon-
ization and infection.
a role for rnase 7 in the prevention of 
Staphylococcus aureus colonization
S. aureus is a bacterial pathogen that 
has emerged as a leading cause of 
skin and soft tissue infections, includ-
ing cellu litis, folliculitis, and impetigo 
(Daum, 2007; McCaig et al., 2006). In 
addition, the widespread prevalence 
of antibiotic-resistant strains, such as 
methicillin-resistant S. aureus, compli-
cate treatment, creating serious public 
health concerns (Klevens et al., 2007; 
Moran et al., 2006). At any given time, 
approximately one-third of healthy 
individuals in the United States are 
colonized with S. aureus (Graham et 
al., 2006). In addition, colonization is 
a risk factor for developing S. aureus 
infections, including skin infections 
as well as more invasive and poten-
tially life-threatening infections such 
as pneumonia, bacteremia, and sepsis 
(von Eiff et al., 2001). Indeed, eradicat-
ing S. aureus colonization has proven 
to be an effective strategy to prevent 
postoperative S. aureus infections (Bode 
et al., 2010; Darouiche et al., 2010). To 
develop immune-based thera peutic or 
preventative strategies against S. aureus 
colonization and infection, a greater 
understanding of the protective func-
tions of antimicrobial peptides in 
human skin is essential. In the current 
issue, Simanski et al. report on the role 
of the antimicrobial peptide RNase 7 in 
the prevention of S. aureus colonization 
of human skin (Simanski et al., 2010).
Harder and Schroder (2002) first 
identified RNase 7 by extracting it from 
human skin. They demonstrated that this 
antimicrobial peptide exhibited broad-
spectrum antimicrobial activity in vitro 
against microorganisms, including S. 
aureus and E. coli. RNase 7 is consti-
tutively expressed throughout the epi-
dermis but is also present in abundant 
quantities in the stratum corneum of 
healthy human skin (Koten et al., 2009). 
Its expression by cultured primary kerati-
nocytes can be further induced by IL-1β, 
IFN-γ, and bacterial challenge (Harder 
and Schroder, 2002). To evaluate the 
potential role of RNase 7 in protect-
ing against S. aureus skin colonization, 
Simanski et al. (2010) investigated RNase 
7 production in human skin explants in 
the context of bacterial challenge with 
S. aureus. They demonstrate that skin 
extracts derived from the stratum cor-
neum of healthy skin contain significant 
concentrations of active RNase 7 with 
bactericidal activity against S. aureus 
(Figure 1). Furthermore, RNase 7 was 
produced rapidly within 2 hours after S. 
aureus bacterial challenge, resulting in 
high levels of RNase 7 in the stratum cor-
neum. These high levels were sufficient 
to control S. aureus growth effectively 
on the surface of the skin, preventing 
colonization. Additionally, bacter-
icidal activity could be blocked by an 
RNase 7–specific neutralizing antibody, 
confirming that RNase 7 is an essen-
tial antimicrobial peptide produced by 
human skin to control S. aureus growth. 
These findings are consistent with a 
prev ious report demonstrating that 
lower baseline levels of RNase 7 expres-
sion were associated with S. aureus skin 
infections in previously healthy individu-
als (Zanger et al., 2009). Taken together, 
these studies provide evidence that the 
expression level of RNase 7 in the skin 
is an important factor that contributes 
to the susceptibility of human skin to S. 
aureus colonization.
other cutaneous immune responses that 
inhibit S. aureus colonization
Although this study points to a key role 
for RNase 7 in preventing S. aureus col-
onization, other antimicrobial peptides 
have also been implicated in inhibiting 
S. aureus colonization and infection in 
skin. Specifically, β-defensin 3 (hBD-
3) and cathelicidin have potent bacte-
ricidal activity against S. aureus, and 
β-defensin 2 (hBD-2) has bacteriostatic 
activity against S. aureus (Braff et al., 
2005; Harder et al., 1997, 2001). Much 
of the evidence that these antimicrobial 
peptides are important in host defense 
against S. aureus skin infection in vivo 
has come from studying two chronic 
inflammatory skin diseases that represent 
Figure 1. rnase 7 protects against Staphylococcus aureus skin colonization. Rnase 7 is expressed 
constitutively in the epidermis of normal skin and can act as a chemical shield to prevent the growth 
of S. aureus (left). Upon exposure to S. aureus, keratinocytes produce large amounts of Rnase 7, 
which accumulate at high levels in the stratum corneum and prevent colonization by S. aureus 
(center). Addition of an Rnase 7–specific neutralizing antibody blocked the killing of S. aureus in the 
stratum corneum, demonstrating the key role of Rnase 7 in preventing colonization (right).
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extremes in the spectrum of susceptibil-
ity to S. aureus. Patients suffering from 
atopic dermatitis are highly susceptible 
to S. aureus infection, whereas those 
with psoriasis are resistant to infection 
(Ong et al., 2002). Although many fac-
tors likely contribute to this difference, 
a strong association between suscepti-
bility and the expression of antimicro-
bial peptides in human skin has been 
observed. In particular, the antimicrobi-
al peptides hBD-2, hBD-3, and catheli-
cidin have all been shown to be present 
at significantly lower concentrations in 
skin lesions of patients with atopic der-
matitis compared with the levels found 
in skin lesions of patients with psoriasis 
(Ong et al., 2002; Kisich et al., 2008). 
This reduction in antimicrobial peptides 
has been proposed to contribute to the 
increased susceptibility to S. aureus 
colonization and infection in atopic 
dermatitis patients. Although it is tempt-
ing to speculate that decreased RNase 
7 expression may also contribute to the 
increased susceptibility to S. aureus in 
atopic dermatitis, this may not be the 
case because a recent study found a lack 
of correlation between RNase 7 expres-
sion and S. aureus colonization in atopic 
dermatitis (Harder et al., 2010).
There is growing evidence that T-cell 
responses may also play a role in con-
trolling S. aureus colonization and infec-
tion. In the skin of patients with atopic 
dermatitis, the predominance of Th2 
cytokines inhibits the production of 
certain antimicrobial peptides, espe-
cially hBD-2 and hBD-3, which likely 
contributes to increased susceptibil-
ity to S. aureus colonization (Nomura 
et al., 2003). More recently, expression 
of the Th17 cytokines IL-17A and IL-22 
have been demonstrated to upregulate 
the production of several antimicrobial 
peptides, including hBD-2, S100A7 
(psoriasin), S100A8, and S100A9, in 
primary keratinocytes (Liang et al., 
2006). Additionally, a role for Th17 cells 
is supported by studies in mice and 
humans demonstrating that a deficiency 
in IL-17-producing T cells results in an 
increased susceptibility to cutaneous 
S. aureus infection (Cho et al., 2010; 
Milner et al., 2008; Ma et al., 2008; 
Renner et al., 2008). However, a role 
for T-cell responses in modulating the 
expression of RNase 7 in the skin has 
not been described. Further investigation 
will be required to determine whether 
T-cell-derived cytokines can regulate 
RNase 7 expression, thereby influencing 
susceptibility to S. aureus colonization 
and infection in the skin.
Perspectives
With the epidemic of S. aureus infec-
tions and the widespread emergence of 
antibiotic-resistant strains, there is con-
siderable urgency to identify novel ther-
apeutic approaches that combat this 
important human pathogen. Because 
colonization represents a major risk 
factor for infection, decreasing coloni-
zation by S. aureus may be an effective 
preventative strategy. Research into the 
natural antimicrobial peptide defense 
system in human skin has yielded prom-
ising candidates. The work of Simanski 
et al. (2010) highlights the potential of 
one such molecule, RNase 7, an anti-
microbial peptide that is constitutively 
present at sufficient levels in healthy 
human skin to prevent S. aureus colo-
nization. Improved understanding of 
how the expression of this molecule is 
regulated will be crucial in developing 
new strategies to prevent pathogenic 
microbial colonization of skin. As such, 
RNase 7 warrants further investigation 
as a target for future immune-based 
therapeutic strategies against cutaneous 
S. aureus colonization and infection.
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